10.76 USD
+0.05 (+0.47%)
10.76 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 88% to CTNM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 23.8. This target is 121.19% above the current price.
CTNM was analyzed by 13 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about CTNM.
In the previous month the buy percentage consensus was at a similar level.
CTNM was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-24 | Baird | Maintains | Outperform -> Outperform |
| 2025-11-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-25 | Leerink Partners | Initiate | Outperform |
| 2025-08-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-19 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-03-13 | Jones Trading | Initiate | Buy |
| 2025-03-07 | Baird | Maintains | Outperform -> Outperform |
| 2025-01-09 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-22 | Baird | Initiate | Outperform |
| 2024-08-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-04-30 | RBC Capital | Initiate | Outperform |
| 2024-04-30 | Stifel | Initiate | Buy |
| 2024-04-30 | Morgan Stanley | Initiate | Overweight |
CONTINEUM THERAPEUTICS INC-A / CTNM FAQ
What is the average price target for CONTINEUM THERAPEUTICS INC-A (CTNM) stock?
13 analysts have analysed CTNM and the average price target is 23.8 USD. This implies a price increase of 121.19% is expected in the next year compared to the current price of 10.76.
How do analysts rate CONTINEUM THERAPEUTICS INC-A (CTNM)?
The consensus rating for CONTINEUM THERAPEUTICS INC-A (CTNM) is 87.6923 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for CTNM stock?
The number of analysts covering CONTINEUM THERAPEUTICS INC-A (CTNM) is 13.